Expert Consensus on Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the People's Republic of China

Overview

Journal Int J Chron Obstruct Pulmon Dis

Publisher Dove Medical Press

Specialty Pulmonary Medicine

Date 2014 May 10

PMID 24812503

Citations 39

Authors

Bai-qiang Cai

Shao-Xi Cai

Rong-Chang Chen

Li-Ying Cui

Yu-Lin Feng

Yu-Tong Gu

Shao-Guang Huang

Rong-Yu Liu

Guang-Nan Liu

Huan-Zhong Shi

Yi Shi

Yuan-Lin Song

Tie-Ying Sun

Chang-Zheng Wang

Jing-Lan Wang

Fu-Qiang Wen

Wei Xiao

Yong-Jian Xu

Xi-Xin Yan

Wan-Zhen Yao

Qin Yu

Jing Zhang

Jin-Ping Zheng

Jie Liu

Chun-Xue Bai

Affiliations

Soon will be listed here.

Abstract

Chronic obstructive pulmonary disease (COPD) is a common disease that severely threatens human health. Acute exacerbation of COPD (AECOPD) is a major cause of disease progression and death, and causes huge medical expenditures. This consensus statement represents a description of clinical features of AECOPD in the People's Republic of China and a set of recommendations. It is intended to provide clinical guidelines for community physicians, pulmonologists and other health care providers for the prevention, diagnosis, and treatment of AECOPD.

Citing Articles

Effect of pneumonia on the outcomes of acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Zheng F, Wang X BMC Pulm Med. 2024; 24(1):496.

PMID: 39385140 PMC: 11462751. DOI: 10.1186/s12890-024-03305-1.

Comprehensive comorbidity assessment for the ECOPD: a long-term multi-centre retrospective study.

Lian H, Kou L, Han X, Rui Z, Dong S, Zhang X BMC Pulm Med. 2024; 24(1):487.

PMID: 39367367 PMC: 11451238. DOI: 10.1186/s12890-024-03257-6.

The malnutrition in AECOPD and its association with unfavorable outcomes by comparing PNI, GNRI with the GLIM criteria: a retrospective cohort study.

Zhang X, Wang Y, Xu M, Zhang Y, Lyu Q Front Nutr. 2024; 11:1365462.

PMID: 39183991 PMC: 11341410. DOI: 10.3389/fnut.2024.1365462.

Identification of symptom clusters and change trajectories in patients with acute exacerbation of chronic obstructive pulmonary disease.

Xu M, Yu C, Lin X, Shi J, Pang X, Chen Z Heliyon. 2024; 10(13):e33745.

PMID: 39071711 PMC: 11276911. DOI: 10.1016/j.heliyon.2024.e33745.

Acute exacerbation prediction of COPD based on Auto-metric graph neural network with inspiratory and expiratory chest CT images.

Wang S, Li W, Zeng N, Xu J, Yang Y, Deng X Heliyon. 2024; 10(7):e28724.

PMID: 38601695 PMC: 11004525. DOI: 10.1016/j.heliyon.2024.e28724.

References

Llor C, Moragas A, Hernandez S, Bayona C, Miravitlles M . Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186(8):716-23. DOI: 10.1164/rccm.201206-0996OC. View

Rizkallah J, Paul Man S, Sin D . Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2008; 135(3):786-793. DOI: 10.1378/chest.08-1516. View

Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M . Guidelines for the management of adult lower respiratory tract infections--summary. Clin Microbiol Infect. 2011; 17 Suppl 6:1-24. DOI: 10.1111/j.1469-0691.2011.03602.x. View

Zheng J, Kang J, Huang S, Yao W, Yang L, Bai C . Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet. 2008; 371(9629):2013-8. DOI: 10.1016/S0140-6736(08)60869-7. View

Bertoletti L, Quenet S, Mismetti P, Hernandez L, Martin-Villasclaras J, Tolosa C . Clinical presentation and outcome of venous thromboembolism in COPD. Eur Respir J. 2011; 39(4):862-8. DOI: 10.1183/09031936.00058811. View

Zhu M, Cai B . [Costs of the last hospitalization for patients with acute exacerbation of chronic obstructive pulmonary disease and patients with lung cancer]. Zhonghua Jie He He Hu Xi Za Zhi. 2009; 32(4):258-61. View

Mackay A, Hurst J . COPD exacerbations: causes, prevention, and treatment. Med Clin North Am. 2012; 96(4):789-809. DOI: 10.1016/j.mcna.2012.02.008. View

Koutsokera A, Stolz D, Loukides S, Kostikas K . Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. Chest. 2011; 141(2):396-405. DOI: 10.1378/chest.11-0495. View

Albert P, Calverley P . Drugs (including oxygen) in severe COPD. Eur Respir J. 2008; 31(5):1114-24. DOI: 10.1183/09031936.00116707. View

10.

Wang C, Shang M, Huang K . [Sequential non-invasive following short-term invasive mechanical ventilation in COPD induced hypercapnic respiratory failure]. Zhonghua Jie He He Hu Xi Za Zhi. 2002; 23(4):212-6. View

11.

Chen Y, Yao W, Cai B, Wang H, Deng X, Gao H . Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease. Chin Med J (Engl). 2008; 121(7):587-91. View

12.

Miravitlles M, Anzueto A . Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 188(9):1052-7. DOI: 10.1164/rccm.201302-0289PP. View

13.

Vestbo J, Hurd S, Agusti A, Jones P, Vogelmeier C, Anzueto A . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2012; 187(4):347-65. DOI: 10.1164/rccm.201204-0596PP. View

14.

Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S . Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007; 176(8):753-60. DOI: 10.1164/rccm.200612-1749OC. View

15.

Perera P, Armstrong E, Sherrill D, Skrepnek G . Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012; 9(2):131-41. DOI: 10.3109/15412555.2011.650239. View

16.

Leuppi J, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T . Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013; 309(21):2223-31. DOI: 10.1001/jama.2013.5023. View

17.

Celli B, MacNee W . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23(6):932-46. DOI: 10.1183/09031936.04.00014304. View

18.

Han M, Martinez F . Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2011; 8(4):356-62. DOI: 10.1513/pats.201102-016RM. View

19.

Mclean S, Nurmatov U, Liu J, Pagliari C, Car J, Sheikh A . Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011; (7):CD007718. PMC: 8939044. DOI: 10.1002/14651858.CD007718.pub2. View

20.

Ye F, He L, Cai B, Wen F, Chen B, Hadiarto M . Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China. Chin Med J (Engl). 2013; 126(12):2207-14. View